(Israel 21st Century) Se-cure's flagship product Femarelle, which is now available in 15 countries around the world, is derived through a unique enzymatic procedure that creates a specific biochemical composition proven to combine the treatment of menopausal symptom relief and bone loss.
"Femarelle activates the estrogen to relieve menopausal symptoms and help prevent osteoporosis, but it won't activate the estrogen where it's not wanted, like in the breasts or the uterus," Yoles told ISRAEL21c.
He explained that for such a therapy to be safe, it must be selective - affecting estrogen receptors only in specific sites without affecting tissues where any change can have dangerous consequences. Which is exactly what Femarelle does - acting as a novel Selective Estrogen Receptor Modulator (SERM) drug.
Previous (and current) treatments of Menopause involved using hormone drugs, which can produce harmful side affects such as blood clots which can potentially lead to strokes.
Se-cure seeks to avoid this with their product Femarelle, which may be able to effectively help women reduce the affects of menopause upon their bodies.
Disclaimer: As I am not a doctor, and it is highly recommended that you consult your physician's advice before considering this product.
Want more good news about Israel?
Enter your email address below to subscribe!
Have a feed reader? Subscribe via RSS or Atom.